Sequoia Financial Advisors LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 79.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 52,290 shares of the healthcare conglomerate's stock after purchasing an additional 23,136 shares during the period. Sequoia Financial Advisors LLC's holdings in UnitedHealth Group were worth $27,387,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. NewSquare Capital LLC bought a new position in UnitedHealth Group in the 4th quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the 4th quarter worth about $26,000. Hurley Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. Finally, Promus Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $32,000. Institutional investors own 87.86% of the company's stock.
UnitedHealth Group Stock Performance
NYSE:UNH traded up $6.23 during midday trading on Friday, reaching $308.85. The stock had a trading volume of 13,584,804 shares, compared to its average volume of 7,465,895. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The firm's fifty day simple moving average is $339.15 and its 200-day simple moving average is $456.28. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a market capitalization of $280.17 billion, a P/E ratio of 12.93, a PEG ratio of 1.43 and a beta of 0.44.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 earnings per share. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a dividend of $2.21 per share. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.86%. UnitedHealth Group's payout ratio is presently 37.02%.
Insider Transactions at UnitedHealth Group
In other UnitedHealth Group news, Director Kristen Gil bought 3,700 shares of the firm's stock in a transaction dated Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the transaction, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO John F. Rex bought 17,175 shares of the firm's stock in a transaction dated Friday, May 16th. The shares were acquired at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the transaction, the chief financial officer now owns 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have purchased 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on the stock. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Royal Bank Of Canada cut their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. TD Securities reissued a "hold" rating and set a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. UBS Group cut their target price on shares of UnitedHealth Group from $400.00 to $385.00 and set a "buy" rating for the company in a research note on Wednesday. Finally, Mizuho decreased their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $415.57.
Get Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report